Abcellera Biologics Inc.
Vancouver, BC
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 150 W 4th Ave, Vancouver, BC V5Y 1G4, Canada
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $196,000 |
| FY2023 | $492,000 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Transgenic mice for human genome antibodies | CDC Pittsburgh | $884,000 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| D18AC00002 | Interior Business Center (DO) | $4,186,283 |
Quick answers
Is Abcellera Biologics Inc. registered in SAM.gov?
Yes. Abcellera Biologics Inc.'s SAM.gov registration is active through July 9, 2027.
What is Abcellera Biologics Inc.'s CAGE code?
Abcellera Biologics Inc.'s CAGE code is L06K8, and its Unique Entity ID (UEI) is D3LSBFZ6MXE3.
How much has Abcellera Biologics Inc. received in federal contracts?
Federal contracts obligated $688,000 to Abcellera Biologics Inc. in fiscal years 2023 through 2027.
What is Abcellera Biologics Inc.'s most recent federal award?
Abcellera Biologics Inc.'s most recent federal contract award is Transgenic mice for human genome antibodies (75D30122C14450), from CDC Pittsburgh, on August 3, 2022.
On GovTribe
See Abcellera Biologics Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors